Professor Erin Howden Joins Race Oncology SAB

Race Oncology is pleased to announce that international cardiometabolic expert, Associate Professor Erin Howden has been appointed to Race’s Scientific Advisory Board. Dr. Howden brings a wealth of experience to Race, having published more than 100 scientific publications on numerous topics, including the serious adverse effects that chemotherapy has on the cardiovascular fitness of cancer patients.

• Associate Professor Erin Howden is a world-leading expert on the serious negative effects of chemotherapy on cardiorespiratory fitness and patient quality of life

• Head of the Cardiometabolic Health and Exercise Physiology Lab and co-lead of the Physical Activity Program at the Baker Heart and Diabetes Institute

• Appointment enhances Race’s cardioprotection-focused clinical program.